Fund profile
Tickers
LABU
Fund manager
Total assets
$1.25 bn
Liabilities
$220.85 mm
Net assets
$1.03 bn
Number of holdings
134.00
LABU stock data
134 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) | 196.47 mm | 196.47 mm principal | 19.02 | Short-term investment vehicle | Long | USA |
GOLDMAN FINL SQ TRSRY INST 506 | 103.52 mm | 103.52 mm principal | 10.02 | Short-term investment vehicle | Long | USA |
DREYFUS TRSRY SECURITIES CASH MGMT | 35.04 mm | 35.04 mm principal | 3.39 | Short-term investment vehicle | Long | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Bank of America N.A. (formerly Merrill Lynch)
|
35.00 mm | 1.00 contracts | 3.39 | Equity derivative | N/A | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Goldman Sachs & Co. LLC
|
31.34 mm | 1.00 contracts | 3.03 | Equity derivative | N/A | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
BNP Paribas
|
28.17 mm | 1.00 contracts | 2.73 | Equity derivative | N/A | USA |
CYTK Cytokinetics Inc | 19.75 mm | 252.78 k shares | 1.91 | Common equity | Long | USA |
GOLDMAN SACHS FIN GOV 465 INSTITUT | 15.54 mm | 15.54 mm principal | 1.50 | Short-term investment vehicle | Long | USA |
KRTX Karuna Therapeutics Inc | 13.15 mm | 41.94 k shares | 1.27 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 11.78 mm | 99.03 k shares | 1.14 | Common equity | Long | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Barclays Bank PLC
|
11.76 mm | 1.00 contracts | 1.14 | Equity derivative | N/A | USA |
BHVN Biohaven Ltd. | 11.60 mm | 260.75 k shares | 1.12 | Common equity | Long | Virgin Islands (British) |
ARDX Ardelyx Inc | 11.53 mm | 1.32 mm shares | 1.12 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 11.25 mm | 350.53 k shares | 1.09 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 10.86 mm | 152.10 k shares | 1.05 | Common equity | Long | USA |
MRNA Moderna Inc | 10.84 mm | 107.31 k shares | 1.05 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 10.67 mm | 24.63 k shares | 1.03 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 10.65 mm | 410.87 k shares | 1.03 | Common equity | Long | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
UBS AG
|
10.32 mm | 1.00 contracts | 1.00 | Equity derivative | N/A | USA |
NBIX Neurocrine Biosciences, Inc. | 10.27 mm | 73.50 k shares | 0.99 | Common equity | Long | USA |
AMGN AMGEN Inc. | 10.07 mm | 32.04 k shares | 0.97 | Common equity | Long | USA |
NTRA Natera Inc | 9.78 mm | 148.25 k shares | 0.95 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 9.73 mm | 350.54 k shares | 0.94 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 9.67 mm | 10.26 k shares | 0.94 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 9.58 mm | 396.79 k shares | 0.93 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 9.56 mm | 673.79 k shares | 0.93 | Common equity | Long | USA |
ABBV Abbvie Inc | 9.50 mm | 57.76 k shares | 0.92 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 9.49 mm | 763.63 k shares | 0.92 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 9.40 mm | 213.06 k shares | 0.91 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 9.37 mm | 433.81 k shares | 0.91 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 9.27 mm | 116.53 k shares | 0.90 | Common equity | Long | USA |
INCY Incyte Corp. | 9.26 mm | 157.58 k shares | 0.90 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 9.26 mm | 1.20 mm shares | 0.90 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 9.17 mm | 121.98 k shares | 0.89 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 9.14 mm | 970.84 k shares | 0.88 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 9.10 mm | 177.05 k shares | 0.88 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 9.09 mm | 265.06 k shares | 0.88 | Common equity | Long | USA |
ALKS Alkermes plc | 9.02 mm | 333.33 k shares | 0.87 | Common equity | Long | Ireland |
KRYS Krystal Biotech Inc | 8.97 mm | 80.67 k shares | 0.87 | Common equity | Long | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
J.P. MORGAN SECURITIES LLC.
|
8.97 mm | 1.00 contracts | 0.87 | Equity derivative | N/A | USA |
MDGL Madrigal Pharmaceuticals Inc | 8.97 mm | 41.37 k shares | 0.87 | Common equity | Long | USA |
TGTX TG Therapeutics Inc | 8.91 mm | 548.35 k shares | 0.86 | Common equity | Long | USA |
BIIB Biogen Inc | 8.89 mm | 36.03 k shares | 0.86 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd | 8.77 mm | 876.89 k shares | 0.85 | Common equity | Long | Bermuda |
ALNY Alnylam Pharmaceuticals Inc | 8.77 mm | 50.71 k shares | 0.85 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 8.71 mm | 133.19 k shares | 0.84 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 8.70 mm | 137.41 k shares | 0.84 | Common equity | Long | USA |
IMGN Immunogen, Inc. | 8.65 mm | 295.12 k shares | 0.84 | Common equity | Long | USA |
INSM Insmed Inc | 8.57 mm | 308.28 k shares | 0.83 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 8.56 mm | 234.55 k shares | 0.83 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 8.54 mm | 109.09 k shares | 0.83 | Common equity | Long | USA |
EXEL Exelixis Inc | 8.53 mm | 391.81 k shares | 0.83 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 8.52 mm | 326.41 k shares | 0.82 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 8.41 mm | 133.55 k shares | 0.81 | Common equity | Long | Switzerland |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 8.17 mm | 92.75 k shares | 0.79 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 8.08 mm | 185.64 k shares | 0.78 | Common equity | Long | USA |
IMVT Immunovant Inc | 8.01 mm | 219.95 k shares | 0.78 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 7.96 mm | 326.17 k shares | 0.77 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 7.94 mm | 387.29 k shares | 0.77 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 7.66 mm | 35.67 k shares | 0.74 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 7.56 mm | 294.67 k shares | 0.73 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 7.30 mm | 215.77 k shares | 0.71 | Common equity | Long | USA |
TWST Twist Bioscience Corp | 7.14 mm | 220.45 k shares | 0.69 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 7.08 mm | 297.02 k shares | 0.68 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 6.70 mm | 518.77 k shares | 0.65 | Common equity | Long | USA |
ACLX Arcellx Inc | 6.65 mm | 107.49 k shares | 0.64 | Common equity | Long | USA |
NVAX Novavax, Inc. | 6.19 mm | 1.55 mm shares | 0.60 | Common equity | Long | USA |
MORF Morphic Holding Inc | 6.17 mm | 194.65 k shares | 0.60 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 6.12 mm | 138.60 k shares | 0.59 | Common equity | Long | USA |
VERA Vera Therapeutics Inc - Ordinary Shares | 5.97 mm | 163.94 k shares | 0.58 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 5.75 mm | 200.19 k shares | 0.56 | Common equity | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 5.69 mm | 135.83 k shares | 0.55 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 5.65 mm | 199.15 k shares | 0.55 | Common equity | Long | Ireland |
RYTM Rhythm Pharmaceuticals Inc. | 5.15 mm | 116.80 k shares | 0.50 | Common equity | Long | USA |
CLDX Celldex Therapeutics Inc. | 5.01 mm | 142.11 k shares | 0.48 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc | 4.95 mm | 309.13 k shares | 0.48 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals Inc | 4.87 mm | 338.12 k shares | 0.47 | Common equity | Long | USA |
BCRX Biocryst Pharmaceuticals Inc. | 4.86 mm | 917.48 k shares | 0.47 | Common equity | Long | USA |
VCEL Vericel Corp | 4.37 mm | 101.60 k shares | 0.42 | Common equity | Long | USA |
ETNB 89bio Inc | 4.31 mm | 435.59 k shares | 0.42 | Common equity | Long | USA |
CABA Cabaletta Bio Inc | 4.11 mm | 200.92 k shares | 0.40 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 4.10 mm | 345.76 k shares | 0.40 | Common equity | Long | USA |
PTGX Protagonist Therapeutics Inc | 4.03 mm | 161.10 k shares | 0.39 | Common equity | Long | USA |
VCYT Veracyte Inc | 3.83 mm | 153.11 k shares | 0.37 | Common equity | Long | USA |
INBX Inhibrx Inc | 3.82 mm | 99.12 k shares | 0.37 | Common equity | Long | USA |
KYMR Kymera Therapeutics Inc | 3.78 mm | 115.40 k shares | 0.37 | Common equity | Long | USA |
VRDN Viridian Therapeutics Inc | 3.74 mm | 194.42 k shares | 0.36 | Common equity | Long | USA |
TVTX Travere Therapeutics Inc | 3.68 mm | 412.06 k shares | 0.36 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 3.65 mm | 241.38 k shares | 0.35 | Common equity | Long | USA |
VIR Vir Biotechnology Inc | 3.60 mm | 383.06 k shares | 0.35 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 3.58 mm | 108.65 k shares | 0.35 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 3.52 mm | 164.56 k shares | 0.34 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 3.47 mm | 62.68 k shares | 0.34 | Common equity | Long | USA |
REPL Replimune Group Inc | 3.45 mm | 444.91 k shares | 0.33 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 3.42 mm | 226.93 k shares | 0.33 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 3.37 mm | 157.50 k shares | 0.33 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 3.33 mm | 147.37 k shares | 0.32 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 3.31 mm | 125.15 k shares | 0.32 | Common equity | Long | USA |
VERV Verve Therapeutics Inc | 3.17 mm | 292.81 k shares | 0.31 | Common equity | Long | USA |
GERN Geron Corp. | 2.95 mm | 1.60 mm shares | 0.29 | Common equity | Long | USA |
KURA Kura Oncology Inc | 2.93 mm | 145.24 k shares | 0.28 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 2.91 mm | 314.49 k shares | 0.28 | Common equity | Long | USA |
ADMA Adma Biologics Inc | 2.71 mm | 522.64 k shares | 0.26 | Common equity | Long | USA |
MNKD Mannkind Corp | 2.62 mm | 784.53 k shares | 0.25 | Common equity | Long | USA |
IRON Disc Medicine Inc | 2.52 mm | 38.27 k shares | 0.24 | Common equity | Long | USA |
CDMO Avid Bioservices Inc | 2.48 mm | 365.96 k shares | 0.24 | Common equity | Long | USA |
EDIT Editas Medicine Inc | 2.40 mm | 342.09 k shares | 0.23 | Common equity | Long | USA |
IBRX ImmunityBio Inc | 2.39 mm | 710.30 k shares | 0.23 | Common equity | Long | USA |
SLNO Soleno Therapeutics Inc | 2.31 mm | 49.81 k shares | 0.22 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 2.31 mm | 420.17 k shares | 0.22 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 2.30 mm | 188.40 k shares | 0.22 | Common equity | Long | USA |
CRBU Caribou Biosciences Inc | 2.24 mm | 366.00 k shares | 0.22 | Common equity | Long | USA |
RAPT RAPT Therapeutics Inc | 2.18 mm | 87.90 k shares | 0.21 | Common equity | Long | USA |
XNCR Xencor Inc | 2.15 mm | 115.04 k shares | 0.21 | Common equity | Long | USA |
ALPN Alpine Immune Sciences Inc | 2.05 mm | 76.97 k shares | 0.20 | Common equity | Long | USA |
QURE uniQure N.V. | 1.97 mm | 354.07 k shares | 0.19 | Common equity | Long | Netherlands |
DCPH Deciphera Pharmaceuticals Inc | 1.92 mm | 134.02 k shares | 0.19 | Common equity | Long | USA |
BMEA Biomea Fusion Inc | 1.76 mm | 97.62 k shares | 0.17 | Common equity | Long | USA |
KNSA Kiniksa Pharmaceuticals Ltd - Ordinary Shares | 1.62 mm | 92.04 k shares | 0.16 | Common equity | Long | Bermuda |
CDNA Caredx Inc | 1.56 mm | 182.81 k shares | 0.15 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 1.44 mm | 103.41 k shares | 0.14 | Common equity | Long | USA |
RGNX Regenxbio Inc | 1.43 mm | 116.01 k shares | 0.14 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 1.42 mm | 82.04 k shares | 0.14 | Common equity | Long | USA |
MDXG Mimedx Group Inc | 1.35 mm | 174.45 k shares | 0.13 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corporation | 1.33 mm | 222.78 k shares | 0.13 | Common equity | Long | USA |
MGNX Macrogenics Inc | 1.30 mm | 90.96 k shares | 0.13 | Common equity | Long | USA |
BLUE Bluebird bio Inc | 1.28 mm | 1.25 mm shares | 0.12 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 1.23 mm | 277.16 k shares | 0.12 | Common equity | Long | USA |
ALEC Alector Inc | 1.09 mm | 183.29 k shares | 0.11 | Common equity | Long | USA |
SCLX Scilex Holding Company | 1.02 mm | 620.13 k shares | 0.10 | Common equity | Long | USA |
Achillion Pharmace SHS
|
0 | 102.55 k shares | 0.00 | Common equity | Long | USA |
OABI OmniAb Inc | 0 | 14.78 k shares | 0.00 | Common equity | Long | USA |
OABI OmniAb Inc | 0 | 14.78 k shares | 0.00 | Common equity | Long | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Citibank National Association
|
-3.85 mm | 1.00 contracts | -0.37 | Equity derivative | N/A | USA |